{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:44:12Z","timestamp":1793515452227,"version":"4.5.0"},"reference-count":55,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am Soc Clin Oncol Educ Book"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Changes to sexual function after cancer treatment are extremely prevalent, affecting up to 90% of female patients with cancer and 40%-85% of male patients with cancer. Sexual health concerns include low libido, genitourinary syndrome of menopause, dyspareunia, erectile dysfunction (ED), hypogonadism, body image concerns, and impacts on intimate relationships. Given the significant impact of sexual dysfunction on quality of life, oncology professionals should integrate sexual health discussions into routine patient care, regardless of the patient's age, sex, or cancer type. Sexuality is best understood in a biopsychosocial framework and cancer treatments including chemotherapy, surgery, radiation, and endocrine therapy can affect all of these domains. Management of genitourinary syndrome of menopause includes nonhormonal and low-dose local hormonal options. Pelvic floor dysfunction and vaginal stenosis can be treated with pelvic floor physical therapy and use of vaginal dilator therapy. ED can be treated with phosphodiesterase type 5 inhibitors and if needed, interventions such as intracavernosal injection of vasoactive agents, urethral suppositories, vacuum erection devices, and surgical implants are available. Cancer treatments such as chemotherapy, radiation, and androgen-deprivation therapy can lead to hypogonadism in men, which can be treated with testosterone therapy, unless contraindicated. Psychosocial counseling, sex therapy, and couples counseling are options for impact to sexual response, body image, and relationship concerns. A comprehensive, patient-centered approach to sexual health can help improve outcomes and overall well-being for cancer survivors.<\/jats:p>","DOI":"10.1200\/edbk-25-472856","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:59:35Z","timestamp":1743641975000},"source":"Crossref","is-referenced-by-count":21,"title":["Enhancing Sexual Health for Cancer Survivors"],"prefix":"10.1200","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1585-7396","authenticated-orcid":false,"given":"Laila S.","family":"Agrawal","sequence":"first","affiliation":[{"name":"Norton Cancer Institute, Louisville, KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"O'Riordan","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-8184","authenticated-orcid":false,"given":"Caleb","family":"Natale","sequence":"additional","affiliation":[{"name":"Tulane University, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-673X","authenticated-orcid":false,"given":"Lawrence C.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Tulane University, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35057"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102236"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae242"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.sxmr.2018.12.001","article-title":"Sexual function in women with colorectal\/anal cancer","volume":"7","author":"Canty J","year":"2019","unstructured":"Canty J, Stabile C, Milli L, et al: Sexual function in women with colorectal\/anal cancer. Sex Med Rev 7:202-222, 2019","journal-title":"Sex Med Rev"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29675"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1007\/s12094-023-03311-5","article-title":"Overview of sexual dysfunction in patients with cancer","volume":"25","author":"Ospina-Serrano AV","year":"2023","unstructured":"Ospina-Serrano AV: Overview of sexual dysfunction in patients with cancer. Clin Transl Oncol 25:3369-3377, 2023","journal-title":"Clin Transl Oncol"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","first-page":"155798832093720","DOI":"10.1177\/1557988320937200","article-title":"Epidemiology of male sexual dysfunction in asian and European regions: A systematic review","volume":"14","author":"Irfan M","year":"2020","unstructured":"Irfan M, Hussain NHN, Noor NM, et al: Epidemiology of male sexual dysfunction in asian and European regions: A systematic review. Am J Mens Health 14:1557988320937200, 2020","journal-title":"Am J Mens Health"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X714197"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70162-0"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2020.08.003"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Hanson A Guglielmino J Ormerod C et al: The changing informational needs of young women affected by breast cancer: A national needs assessment. Cancer Research 83 2023 (abstr PD8-07)","DOI":"10.1158\/1538-7445.SABCS22-PD8-07"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.07.872"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-016-0577-9"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0000000000000186"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.11029","article-title":"Hematology and oncology fellow education about sexual and reproductive health: A survey of program directors in the United States","volume":"41","author":"Reese JB","year":"2023","unstructured":"Reese JB, Bauman JR, Sorice KA, et al: Hematology and oncology fellow education about sexual and reproductive health: A survey of program directors in the United States. J Clin Oncol 41, 2023 (suppl 16; abstr 11029)","journal-title":"J Clin Oncol"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/EDBK_100032","article-title":"Sexuality after cancer as an unmet need: Addressing disparities, achieving equality","volume":"42","author":"Katz A","year":"2022","unstructured":"Katz A, Agrawal LS, Sirohi B: Sexuality after cancer as an unmet need: Addressing disparities, achieving equality. Am Soc Clin Oncol Educ Book 42:11-17, 2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"611954","DOI":"10.3389\/fpsyg.2021.611954","article-title":"The efficacy of psychological intervention on body image in breast cancer patients and survivors: A systematic-review and meta-analysis","volume":"12","author":"Sebri V","year":"2021","unstructured":"Sebri V, Durosini I, Triberti S, et al: The efficacy of psychological intervention on body image in breast cancer patients and survivors: A systematic-review and meta-analysis. Front Psychol 12:611954, 2021","journal-title":"Front Psychol"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18041640"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1188\/05.ONF.E30-E41","article-title":"Prostate cancer survivors\u2019 and partners\u2019 self-reports of health-related quality of life, treatment symptoms, and marital satisfaction 2.5-5.5 years after treatment","volume":"32","author":"Galbraith ME","year":"2005","unstructured":"Galbraith ME, Arechiga A, Ramirez J, et al: Prostate cancer survivors\u2019 and partners\u2019 self-reports of health-related quality of life, treatment symptoms, and marital satisfaction 2.5-5.5 years after treatment. Oncol Nurs Forum 32:E30-E41, 2005","journal-title":"Oncol Nurs Forum"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.8995"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3333-3"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900857"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall JP","year":"2018","unstructured":"Mulhall JP, Trost LW, Brannigan RE, et al: Evaluation and management of testosterone deficiency: AUA guideline. J Urol 200:423-432, 2018","journal-title":"J Urol"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001121"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/13697137.2015.1124259","article-title":"Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: How important is vaginal lubricant and moisturizer composition?","volume":"19","author":"Edwards D","year":"2016","unstructured":"Edwards D, Panay N: Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: How important is vaginal lubricant and moisturizer composition? Climacteric 19:151-161, 2016","journal-title":"Climacteric"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05472-3"},{"key":"e_1_3_3_28_2","volume-title":"Use and Procurement of Additional Lubricants for Male and Female Condoms: WHO\/UNFPA\/FHI360: Advisory Note","author":"WHO","year":"2012","unstructured":"WHO: Use and Procurement of Additional Lubricants for Male and Female Condoms: WHO\/UNFPA\/FHI360: Advisory Note. WHO, 2012. https:\/\/apps.who.int\/iris\/handle\/10665\/76580"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djac112"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/jnci\/djac213","article-title":"RE: Systemic or vaginal hormone therapy after early breast cancer: A Danish observational cohort study","volume":"115","author":"Chlebowski RT","year":"2023","unstructured":"Chlebowski RT, Aragaki AK, Pan K: RE: Systemic or vaginal hormone therapy after early breast cancer: A Danish observational cohort study. J Natl Cancer Inst 115:222-223, 2023","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett AL","year":"2018","unstructured":"Burnett AL, Nehra A, Breau RH, et al: Erectile dysfunction: AUA guideline. J Urol 200:633-641, 2018","journal-title":"J Urol"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","article-title":"Vaginal estrogen therapy use and survival in females with breast cancer","volume":"10","author":"McVicker L","year":"2024","unstructured":"McVicker L, Labeit AM, Coupland CAC, et al: Vaginal estrogen therapy use and survival in females with breast cancer. JAMA Oncol 10:103-108, 2024","journal-title":"JAMA Oncol"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/AOG.0000000000005294","article-title":"Safety of vaginal estrogen therapy for genitourinary syndrome of menopause in women with a history of breast cancer","volume":"142","author":"Agrawal P","year":"2023","unstructured":"Agrawal P, Singh SM, Able C, et al: Safety of vaginal estrogen therapy for genitourinary syndrome of menopause in women with a history of breast cancer. Obstet Gynecol 142:660-668, 2023","journal-title":"Obstet Gynecol"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/13697137.2022.2050208","article-title":"Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: The VIBRA pilot study","volume":"25","author":"Mension E","year":"2022","unstructured":"Mension E, Alonso I, Cebrecos I, et al: Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: The VIBRA pilot study. Climacteric 25:476-482, 2022","journal-title":"Climacteric"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2019.07.001"},{"key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"e28705","DOI":"10.1097\/MD.0000000000028705","article-title":"Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors","volume":"101","author":"Charatsi D","year":"2022","unstructured":"Charatsi D, Vanakara P, Evaggelopoulou E, et al: Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors. Medicine (Baltimore) 101:e28705, 2022","journal-title":"Medicine (Baltimore)"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12885-021-08274-w","article-title":"Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: A randomized clinical trial","volume":"21","author":"Martins J","year":"2021","unstructured":"Martins J, Vaz AF, Grion RC, et al: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: A randomized clinical trial. BMC Cancer 21:682, 2021","journal-title":"BMC Cancer"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/0092623X.2022.2154296"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05395-6"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003500"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1513686"},{"key":"e_1_3_3_42_2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.12015","article-title":"Effect of flibanserin on libido in women with breast cancer on adjuvant endocrine therapy","volume":"41","author":"Goldfarb SB","year":"2023","unstructured":"Goldfarb SB, Carter J, Arkema A, et al: Effect of flibanserin on libido in women with breast cancer on adjuvant endocrine therapy. J Clin Oncol 41, 2023 (suppl 16; abstr 12015)","journal-title":"J Clin Oncol"},{"key":"e_1_3_3_43_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnbot.2020.00024","article-title":"Using bionics to restore sensation to reconstructed breasts","volume":"14","author":"Lindau ST","year":"2020","unstructured":"Lindau ST, Bensmaia SJ: Using bionics to restore sensation to reconstructed breasts. Front Neurorobot 14:24, 2020","journal-title":"Front Neurorobot"},{"key":"e_1_3_3_44_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ucl.2021.06.009","article-title":"Physiology of erection and pathophysiology of erectile dysfunction","volume":"48","author":"MacDonald SM","year":"2021","unstructured":"MacDonald SM, Burnett AL: Physiology of erection and pathophysiology of erectile dysfunction. Urol Clin North Am 48:513-525, 2021","journal-title":"Urol Clin North Am"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/nrdp.2016.3","article-title":"Erectile dysfunction","volume":"2","author":"Yafi FA","year":"2016","unstructured":"Yafi FA, Jenkins L, Albersen M, et al: Erectile dysfunction. Nat Rev Dis Primers 2:16003, 2016","journal-title":"Nat Rev Dis Primers"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/andr.13212","article-title":"Primary organic versus primary psychogenic erectile dysfunction: Findings from a real-life cross-sectional study","volume":"10","author":"Pozzi E","year":"2022","unstructured":"Pozzi E, Fallara G, Capogrosso P, et al: Primary organic versus primary psychogenic erectile dysfunction: Findings from a real-life cross-sectional study. Andrology 10:1302-1309, 2022","journal-title":"Andrology"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.eururo.2013.08.023","article-title":"A systematic review of the association between erectile dysfunction and cardiovascular disease","volume":"65","author":"Gandaglia G","year":"2014","unstructured":"Gandaglia G, Briganti A, Jackson G, et al: A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol 65:968-978, 2014","journal-title":"Eur Urol"},{"key":"e_1_3_3_48_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jsxmed\/qdac042","article-title":"Role of psychosexual counseling as an adjuvant to pharmacotherapy in the treatment of erectile dysfunction","volume":"20","author":"Althof SE","year":"2023","unstructured":"Althof SE: Role of psychosexual counseling as an adjuvant to pharmacotherapy in the treatment of erectile dysfunction. J Sex Med 20:236-239, 2023","journal-title":"J Sex Med"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-5347(17)44267-4","article-title":"Physiology of erection and pharmacological management of impotence","volume":"137","author":"Lue TF","year":"1987","unstructured":"Lue TF, Tanagho EA: Physiology of erection and pharmacological management of impotence. J Urol 137:829-836, 1987","journal-title":"J Urol"},{"key":"e_1_3_3_50_2","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1046\/j.0306-5251.2001.00027.x","article-title":"Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: Absolute bioavailability, food effects and dose proportionality","volume":"53","author":"Nichols DJ","year":"2002","unstructured":"Nichols DJ, Muirhead GJ, Harness JA: Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: Absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol 53:5S-12S, 2002 (suppl 1)","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14656566.2023.2204189","article-title":"Current status of intracavernosal injection therapy in erectile dysfunction","volume":"24","author":"Elena BW","year":"2023","unstructured":"Elena BW, Zachary M, Haritha P, et al: Current status of intracavernosal injection therapy in erectile dysfunction. Expert Opin Pharmacother 24:925-933, 2023","journal-title":"Expert Opin Pharmacother"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12046"},{"key":"e_1_3_3_53_2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41585-022-00607-z","article-title":"The International Penile Prosthesis Implant Consensus Forum: Clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant","volume":"19","author":"Chung E","year":"2022","unstructured":"Chung E, Bettocchi C, Egydio P, et al: The International Penile Prosthesis Implant Consensus Forum: Clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant. Nat Rev Urol 19:534-546, 2022","journal-title":"Nat Rev Urol"},{"key":"e_1_3_3_54_2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2213-8587(24)00199-2","article-title":"Male hypogonadism: Pathogenesis, diagnosis, and management","volume":"12","author":"De Silva NL","year":"2024","unstructured":"De Silva NL, Papanikolaou N, Grossmann M, et al: Male hypogonadism: Pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 12:761-774, 2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/clinem\/dgad484","article-title":"Effect of testosterone replacement therapy on sexual function and hypogonadal symptoms in men with hypogonadism","volume":"109","author":"Pencina KM","year":"2024","unstructured":"Pencina KM, Travison TG, Cunningham GR, et al: Effect of testosterone replacement therapy on sexual function and hypogonadal symptoms in men with hypogonadism. J Clin Endocrinol Metab 109:569-580, 2024","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_56_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of Urology guidelines on sexual and reproductive health-2021 update: Male sexual dysfunction","volume":"80","author":"Salonia A","year":"2021","unstructured":"Salonia A, Bettocchi C, Boeri L, et al: European Association of Urology guidelines on sexual and reproductive health-2021 update: Male sexual dysfunction. Eur Urol 80:333-357, 2021","journal-title":"Eur Urol"}],"container-title":["American Society of Clinical Oncology Educational Book"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/EDBK-25-472856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T15:20:35Z","timestamp":1743780035000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/EDBK-25-472856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1200\/EDBK-25-472856"],"URL":"https:\/\/doi.org\/10.1200\/edbk-25-472856","relation":{},"ISSN":["1548-8748","1548-8756"],"issn-type":[{"value":"1548-8748","type":"print"},{"value":"1548-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"article-number":"e472856"}}